PFSA
Profusa, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Strong sell
-57/100
Last price
1.64
▼ 0.11 (6.29%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.78
Prev close
1.75
Day high
1.73
Day low
1.60
Volume
264.91K
Market cap
$1.01M
P/E (TTM)
0.00
52W range
1.58 – 3,000.00
Day trading desk
Gap from prior close
+1.71%
Prior close 1.75
VWAP
1.67
-1.58% from price
Relative volume
0.19×
Quiet session
Session range
16.87%
1.60 – 1.87
Position in range
15%
Near session low
ATR (14D)
0.51
31.25% of price
Prior day high
1.76
PDH
Prior day low
1.61
PDL
Bid / ask spread
—
Quote not published
Session volume
518.34K
Avg 2.72M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-26.87%
-28.8%
1M
-38.97%
-40.1%
3M
-82.71%
-87.2%
6M
-98.67%
-116.9%
YTD
-99.79%
-114.0%
1Y
-99.93%
-116.4%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PFSA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+574.06K
Net buying
Buy transactions
8
641.62K shares
Sell transactions
5
67.56K shares
Net transactions
+13
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
252.59K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 18.39K | $20.83K | Direct |
| Aug 14, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 3.16K | $2.85K | Direct |
| Aug 13, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 42.41K | $37.66K | Direct |
| Aug 12, 26 | STOVER JACK E Chief Executive Officer |
CONVERSION | 301.99K | $1.29M | Indirect |
| Aug 12, 26 | KNECHTEL FRED S Chief Financial Officer |
CONVERSION | 301.99K | $1.29M | Indirect |
| Aug 12, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
BUY | 5.58K | $5.38K | Direct |
| Aug 11, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 2.28K | $2.21K | Direct |
| Aug 10, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
BUY | 4.02K | $3.79K | Direct |
| Aug 7, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 1.31K | $1.24K | Direct |
| Aug 6, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
BUY | 926 | $873 | Direct |
| Aug 4, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
BUY | 15.92K | $15.25K | Direct |
| Jul 31, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
BUY | 9.87K | $10.32K | Direct |
| Jul 29, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
BUY | 1.31K | $1.32K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
HRT FINANCIAL L.P |
Beneficial Owner of more than 10% of a Class of Security | 0 | Sale |
KNECHTEL FRED S |
Chief Financial Officer | — | Conversion of Exercise of derivative security |
STOVER JACK E |
Chief Executive Officer | — | Conversion of Exercise of derivative security |
Fundamentals
Market cap$1.01M
Enterprise value$14.39M
Revenue (TTM)—
Gross profit—
EBITDA—
Net income$-42.97M
EPS (TTM)$897.26
Free cash flow$-19.13M
Total cash$719.00K
Total debt$14.10M
Book value / share$-205.03
Shares outstanding605.65K
Float518.17K
Short % of float5.21%
Dividend yield0.00%
Beta (5Y)0.50
Valuation & profitability ratios
Trailing P/E0.00
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity—
Return on assets-725.25%
Debt / equity—
Current ratio0.03
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $2.80M | $1.61M | $2.04M | $4.20M | +74.4% |
| Selling, general & admin | $24.90M | $2.99M | $4.08M | $5.24M | +732.3% |
| Total operating expense | $27.71M | $4.50M | $6.07M | $9.44M | +515.7% |
| Operating income | -$27.71M | -$4.50M | -$6.07M | -$9.44M | -515.7% |
| Net interest income | -$5.09M | -$4.42M | -$4.28M | -$6.27M | -15.2% |
| Pre-tax income | -$35.82M | -$9.23M | -$10.28M | -$20.22M | -288.1% |
| Net income | -$35.82M | -$9.23M | -$10.28M | -$20.22M | -288.1% |
| Net income to common | -$35.82M | -$9.23M | -$10.28M | -$20.22M | -288.1% |
| Basic EPS | -10,701.00 | -2,111.64 | -2,352.09 | -4,625.26 | -406.8% |
| Diluted EPS | -10,701.00 | -2,111.64 | -2,352.09 | -4,625.26 | -406.8% |
| EBIT | -$33.30M | -$4.81M | -$6.00M | -$13.95M | -592.9% |
| EBITDA | -$33.30M | -$4.81M | -$6.00M | -$13.22M | -592.9% |
| Basic shares | 3.35K | 4.37K | 4.37K | 4.37K | -23.4% |
| Diluted shares | 3.35K | 4.37K | 4.37K | 4.37K | -23.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.78M | $191.00K | $142.00K | $78.00K | — | +830.9% |
| Cash & short-term investments | $1.78M | $191.00K | $142.00K | $78.00K | — | +830.9% |
| Accounts receivable | — | — | — | $0 | $38.00K | — |
| Total current assets | $3.76M | $260.00K | $333.00K | $160.00K | — | +1,347.7% |
| Property, plant & equipment | $8.00K | $0 | $2.00K | $0 | — | — |
| Total assets | $3.77M | $3.07M | $1.89M | $1.03M | — | +22.8% |
| Total current liabilities | $22.26M | $57.13M | $46.74M | $35.65M | — | -61.0% |
| Current debt | $6.94M | $48.21M | $40.40M | $31.03M | — | -85.6% |
| Long-term debt | $7.88M | — | — | — | $1.19M | — |
| Total debt | $14.81M | $48.21M | $40.40M | $31.03M | — | -69.3% |
| Total liabilities | $30.43M | $122.28M | $111.89M | $100.80M | — | -75.1% |
| Retained earnings | -$160.78M | -$124.96M | -$115.73M | -$105.45M | — | -28.7% |
| Shareholder equity | -$26.66M | -$119.20M | -$110.00M | -$99.77M | — | +77.6% |
| Working capital | -$18.49M | -$56.87M | -$46.41M | -$35.49M | — | +67.5% |
| Net tangible assets | -$26.66M | -$119.20M | -$110.00M | -$99.77M | — | +77.6% |
| Shares issued | 12.32K | 12.32K | 4.37K | 4.37K | — | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$35.82M | -$9.23M | -$10.28M | -$20.22M | — | -288.1% |
| Depreciation & amortisation | — | — | — | $724.00K | $1.18M | — |
| Stock-based compensation | $891.00K | $21.00K | $33.00K | $111.00K | — | +4,142.9% |
| Change in working capital | $4.35M | $2.41M | $1.54M | $909.00K | — | +80.6% |
| Operating cash flow | -$16.25M | -$2.07M | -$4.40M | -$7.70M | — | -686.4% |
| Capital expenditure | -$8.00K | — | -$2.00K | — | — | — |
| Investing cash flow | -$2.01M | $0 | -$2.00K | — | — | — |
| Financing cash flow | $19.84M | $2.12M | $4.47M | $6.92M | — | +838.2% |
| Free cash flow | -$16.26M | -$2.07M | -$4.40M | -$7.70M | — | -686.8% |
| End cash position | $1.78M | $191.00K | $142.00K | $78.00K | — | +830.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — | — |
| Research & development | $823.00K | $1.15M | $1.25M | $722.00K | $393.00K | — | -28.2% |
| Selling, general & admin | $1.72M | $2.86M | $2.31M | $20.99M | $610.00K | — | -39.8% |
| Total operating expense | $2.54M | $4.01M | $3.57M | $21.71M | $1.00M | — | -36.5% |
| Operating income | -$2.54M | -$4.01M | -$3.57M | -$21.71M | -$1.00M | — | +36.5% |
| Net interest income | -$2.43M | -$78.00K | -$1.16M | -$1.61M | -$1.19M | — | -3,016.7% |
| Pre-tax income | -$8.76M | -$3.46M | -$8.57M | -$22.19M | -$2.35M | — | -153.3% |
| Tax provision | — | — | — | — | $2.39K | — | — |
| Net income | -$8.76M | -$3.46M | -$8.57M | -$22.19M | -$2.35M | — | -153.3% |
| Net income to common | -$8.76M | -$3.46M | -$8.57M | -$22.19M | -$2.35M | — | -153.3% |
| Basic EPS | -151.80 | -205.00 | — | -5,250.00 | -537.18 | -621.37 | +26.0% |
| Diluted EPS | -151.80 | -205.00 | — | -5,250.00 | -537.18 | -621.37 | +26.0% |
| EBIT | -$8.73M | -$3.44M | -$8.54M | -$22.02M | -$1.16M | — | -154.0% |
| EBITDA | -$8.73M | -$3.44M | -$8.54M | -$22.02M | -$1.16M | — | -154.0% |
| Basic shares | 57.68K | 16.88K | — | 4.23K | 4.37K | 4.37K | +241.7% |
| Diluted shares | 57.68K | 16.88K | — | 4.23K | 4.37K | 4.37K | +241.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $719.00K | $375.00K | $1.78M | $3.01M | $0 | +91.7% |
| Cash & short-term investments | $719.00K | $375.00K | $1.78M | $3.01M | $0 | +91.7% |
| Total current assets | $841.00K | $662.00K | $3.76M | $4.20M | $687.87K | +27.0% |
| Property, plant & equipment | $154.00K | $159.00K | $8.00K | — | — | -3.1% |
| Total assets | $1.04M | $862.00K | $3.77M | $4.25M | $1.96M | +20.9% |
| Total current liabilities | $28.17M | $29.02M | $22.26M | $23.54M | $16.18M | -2.9% |
| Current debt | $14.00M | $12.54M | $6.94M | $6.71M | $10.29M | +11.7% |
| Long-term debt | — | — | $7.88M | $14.36M | — | — |
| Total debt | $14.00M | $12.54M | $14.81M | $21.07M | $10.29M | +11.7% |
| Total liabilities | $28.17M | $29.06M | $30.43M | $38.21M | $23.14M | -3.1% |
| Retained earnings | -$172.99M | -$164.24M | -$160.78M | -$152.21M | -$22.51M | -5.3% |
| Shareholder equity | -$27.13M | -$28.20M | -$26.66M | -$33.96M | -$21.18M | +3.8% |
| Working capital | -$27.33M | -$28.36M | -$18.49M | -$19.34M | -$15.49M | +3.6% |
| Net tangible assets | -$27.13M | -$28.20M | -$26.66M | -$33.96M | -$21.18M | +3.8% |
| Shares issued | 132.00K | 23.80K | 12.32K | 5.56K | 4.37K | +454.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$8.76M | -$3.46M | -$8.57M | -$22.19M | -$2.35M | -153.3% |
| Stock-based compensation | $188.00K | $187.00K | $187.00K | $622.00K | $77.00K | +0.5% |
| Change in working capital | -$176.00K | $1.23M | -$1.08M | $4.21M | $336.00K | -114.3% |
| Operating cash flow | -$2.63M | -$2.58M | -$5.13M | -$9.99M | -$589.00K | -2.2% |
| Capital expenditure | -$73.00K | -$5.00K | — | — | — | -1,360.0% |
| Investing cash flow | -$73.00K | $1.15M | -$1.01M | -$1.00M | $0 | -106.4% |
| Financing cash flow | $3.05M | $28.00K | $4.91M | $13.96M | $609.00K | +10,789.3% |
| Free cash flow | -$2.71M | -$2.58M | -$5.14M | -$9.99M | -$589.00K | -4.8% |
| End cash position | $719.00K | $375.00K | $1.78M | $3.01M | $39.00K | +91.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders41.71%
Held by institutions3.49%
Institutions holding12
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
2.02
-18.69% from price
SMA 20
2.08
-20.17% from price
SMA 50
3.85
-56.92% from price
SMA 100
12.44
-86.82% from price
SMA 200
157.76
-98.95% from price
EMA 12
2.00
-17.85% from price
EMA 26
2.73
-39.94% from price
EMA 50
6.85
-76.07% from price
RSI (14)
42.3
Neutral
MACD (12,26,9)
-0.73
Hist 0.14
ATR (14)
0.51
30.87% of price
Realised vol 30D
254.0%
Annualised
Bollinger upper
2.80
20, 2σ
Bollinger lower
1.36
20, 2σ
50 / 200 cross
Death
3.85 vs 157.76
Trend bias
Below 200
-98.95%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.06
Less volatile than market
Correlation to SPY
0.00
Largely independent
Realised vol 30D
254.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-99.9%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.51
30.87% of price
Beta (reported)
0.50
5Y monthly, from filing
Short interest
Shares short
31.55K
Prior 10.88K
Change vs prior
+190.0%
Shorts adding
% of float
5.21%
Normal
% of shares out
5.21%
Against total outstanding
Days to cover
0.0
Liquid
Float
518.17K
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:4
Split dateAug 17, 2026
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-05
Corporate Changes & Voting Matters
8-K · 2026-09-21
Corporate Changes & Voting Matters
8-K · 2026-09-16
Corporate Changes & Voting Matters
8-K · 2026-09-15
Corporate Changes & Voting Matters
8-K · 2026-09-01
Corporate Changes & Voting Matters
8-K · 2026-08-31
Proxy Statements
DEF 14A · 2026-08-28
Corporate Changes & Voting Matters
8-K · 2026-08-21
Headlines
Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark
InvestorsHub · 13d ago
BC-Most Active Stocks
Associated Press · 13d ago
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
GlobeNewswire · 13d ago
Profusa, Inc. Receives Nasdaq Compliance Determination
GlobeNewswire · 22d ago
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
GlobeNewswire · 37d ago
Top Midday Decliners
MT Newswires · 48d ago
Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens
InvestorsHub · 48d ago
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
GlobeNewswire · 48d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.